Engineering bioluminescent bacteria to boost photodynamic therapy and systemic anti-tumor immunity for synergistic cancer treatment
Source abstract
Abstract
The limited penetration depth of external excitation light would remarkably impair the therapeutic efficacy of photodynamic therapy (PDT) and its clinical utilization. Herein, we engineered bioluminescent bacteria by transforming attenuated Salmonella typhimurium strain ΔppGpp (S.T.ΔppGpp) with firefly-luciferase-expressing plasmid (Luc-S.T.ΔppGpp) as an internal light source to evenly illuminate whole tumors. Upon being fixed inside tumors with in-situ formed hydrogel, the colonized Luc-S.T.ΔppGpp together with D-luciferin could continuously generate light to excite photosensitizer chlorin e6 (Ce6), leading to effective suppression of different types of tumors including opaque melanoma and large rabbit tumors. Such bioluminescence-triggered PDT presented significant advantages over conventional PDT excited with an external 660-nm light, which at a much high light energy could only slightly retard the growth of small subcutaneous tumors. Furthermore, we uncovered that Luc-S.T.ΔppGpp boosted PDT could also elicit potent antitumor immunity post the treatment to inhibit tumor metastasis and prevent tumor challenge. Therefore, this work highlights that such bioluminescent bacteria boosted PDT is a general and highly effective therapeutic approach toward diverse cancers with varying light-absorbing capacities and tumor sizes, promising for potential clinical translation because of their acceptable safety profiles.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Photodynamic therapy enables tumor-specific ablation in preclinical models of thyroid cancer10.1530/ERC-19-0258 ↗
2. Light‐triggered in situ gelation to enable robust photodynamic‐immunotherapy by repeated stimulations10.1002/adma.201900927 ↗
3. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
4. Co-delivery of bee venom melittin and a photosensitizer with an organic-inorganic hybrid nanocarrier for photodynamic therapy and immunotherapy10.1021/acsnano.9b04181 ↗
5. Photodynamic therapy of cancer: an update10.3322/caac.20114 ↗
6. Design and synthesis of efficient heavy-atom-free photosensitizers for photodynamic therapy of cancer10.1039/D0CC04644B ↗
7. Supramolecular phthalocyanine assemblies for improved photoacoustic imaging and photothermal therapy10.1002/anie.201916147 ↗
8. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
9. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers10.1038/nm.2933 ↗
10. Aggregation-induced emission gold clustoluminogens for enhanced low-dose X-ray-induced photodynamic therapy10.1002/anie.201908712 ↗
11. CT/MRI-Guided synergistic radiotherapy and X-ray inducible photodynamic therapy using Tb-doped Gd-W-nanoscintillators10.1002/anie.201812272 ↗
12. Monodisperse and uniform mesoporous silicate nanosensitizers achieve low-dose X-ray-induced deep-penetrating photodynamic therapy10.1002/adma.201808024 ↗
13. X-ray-Activatable photodynamic nanoconstructs10.1021/acscentsci.0c00303 ↗
14. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers10.1038/nnano.2015.17 ↗
15. Magnetic targeting of nanotheranostics enhances cerenkov radiation-induced photodynamic therapy10.1021/jacs.8b09374 ↗
16. Activatable hybrid nanotheranostics for tetramodal imaging and synergistic photothermal/photodynamic therapy10.1002/adma.201704367 ↗
17. Dual cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy toward tumor resection10.1021/acs.jmedchem.0c00625 ↗
18. A self-illuminating nanoparticle for inflammation imaging and cancer therapy10.1126/sciadv.aat2953 ↗
19. Chemiluminescence-guided cancer therapy using a chemiexcited photosensitizer
20. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis10.1038/s41467-018-07197-8 ↗
21. II. Contribution to the knowledge of sarcoma10.1097/00000658-189112000-00015 ↗
22. Tumour-targeting bacteria engineered to fight cancer10.1038/s41568-018-0070-z ↗
23. Bacteria in cancer therapy: beyond immunostimulation10.20517/2394-4722.2017.49 ↗
24. Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap10.1038/s41467-018-04605-x ↗
25. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin10.1126/scitranslmed.aak9537 ↗
26. Combination of bacterial‐photothermal therapy with an anti‐PD‐1 peptide depot for enhanced immunity against advanced cancer10.1002/adfm.201906623 ↗
27. Programmable bacteria induce durable tumor regression and systemic antitumor immunity10.1038/s41591-019-0498-z ↗
28. Inhibition of tumor progression through the coupling of bacterial respiration with tumor metabolism10.1002/anie.202002649 ↗
29. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story10.1016/j.juro.2007.08.122 ↗
30. Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer10.1126/sciadv.aba3546 ↗
31. Advances in engineering local drug delivery systems for cancer immunotherapy
32. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure10.1038/s41551-020-0582-1 ↗
33. Bacterial therapy of cancer: promises, limitations, and insights for future directions10.3389/fmicb.2018.00016 ↗
34. Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP2000910.1016/j.biopha.2020.110425 ↗
35. Choice of optimal wavelength for PDT: the significance of oxygen depletion10.1562/2005-04-06-RA-478 ↗
36. Hasan · 2018 · 44
37. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring
38. Therapeutic application of light emitting diode: photo-oncomic approach10.1016/j.jphotobiol.2019.01.003 ↗
39. Cancer immunotherapy based on killing of Salmonella-infected tumor cells10.1158/0008-5472.CAN-04-3002 ↗
40. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment10.1126/science.1240527 ↗
41. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity10.1126/scitranslmed.3000739 ↗
42. In vivo IFN-gamma secretion by NK cells in response to Salmonella typhimurium requires NLRC4 inflammasomes10.1371/journal.pone.0097418 ↗
43. Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy10.1021/jacs.6b06663 ↗
44. Bacteria-cancer interactions: bacteria-based cancer therapy10.1038/s12276-019-0297-0 ↗
45. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin10.1126/scitranslmed.aak9537 ↗
46. Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy10.1016/j.biomaterials.2012.08.044 ↗
47. Luciferase–Rose Bengal conjugates for singlet oxygen generation by bioluminescence resonance energy transfer10.1039/C7CC00041C ↗
48. Revisiting the mechanisms involved in calcium chloride induced bacterial transformation10.3389/fmicb.2017.02169 ↗